Soluble angiogenic factors in patients with acute pancreatitis

Journal of Clinical Gastroenterology

Volumn 45, Issue 7, 2011, Pages 630-637

  Espinosa, Laura ^a   Linares, Pablo M ^a   Bejerano, Alicia ^a   Lopez, Cristina ^a   Sanchez, Argeme ^a   Moreno Otero, Ricardo ^a   Gisbert, Javier P ^a  

^a HOSPITAL UNIVERSITARIO DE LA PRINCESA   (Spain)

Author keywords

acute pancreatitis; angiogenesis; angiogenic factors; growth factors; inflammatory diseases

Indexed keywords

ANGIOGENIC FACTOR; ANGIOPOIETIN 1; ANGIOPOIETIN 2; ANGIOPOIETIN RECEPTOR; PLATELET DERIVED GROWTH FACTOR BB; SCATTER FACTOR; VASCULOTROPIN A; VASCULOTROPIN RECEPTOR 1; VASCULOTROPIN RECEPTOR 2;

ACUTE PANCREATITIS; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; GLASGOW OUTCOME SCALE; HOSPITALIZATION; HUMAN; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANSON SCALE; RATING SCALE;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; ANGIOGENESIS INDUCING AGENTS; ANGIOPOIETIN-2; CASE-CONTROL STUDIES; FEMALE; HEPATOCYTE GROWTH FACTOR; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; PANCREATITIS; PLATELET-DERIVED GROWTH FACTOR; PROGNOSIS; SEVERITY OF ILLNESS INDEX; SOLUBILITY;

EID: 79960596784     PISSN: 01920790     EISSN: 15392031     Source Type: Journal    
DOI: 10.1097/MCG.0b013e31820d3533     Document Type: Article

References (41)

1. Mentula P, Kylanpaa ML, Kemppainen E, et al. Serum levels of mast cell tryptase, vascular endotelial growth factor and basic fibroblast growth factor in patients with acute pancreatitis. Pancreas. 2003;27:e29-e33
2. Feldemen DC, Blann AD, Lip GY. Angiogenesis: basic pathophysiology and implications for disease. Eur Heart J. 2003;24:586-603 (Pubitemid 36343192)
3. Pousa ID, Maté J, Gisbert JP. Angiogenensis in inflammatory bowel disease. Eur J Clin Invest. 2008;38:73-81
4. Pousa ID, Gisbert JP, Maté J. Vascular development in inflammatory bowel disease. Gastroenterol Hepatol. 2006;29: 414-421 (Pubitemid 44386357)
5. Pousa ID, Gisbert JP. Gastric angiogenesis and Helicobacter pylori infection. Rev Esp Enferm Dig. 2006;98:527-541 (Pubitemid 350104421)
6. Medina J, Arroyo AG, Sánchez-Madrid F, et al. Angiogenesis in chronic inflammatory liver disease. Hepatology. 2004; 39:1185-1195 (Pubitemid 38569038)
7. Tammela T, Enholm B, Alitalo K, et al. The biology of vascular endothelial growth factors. Cardiovasc Res. 2005;65: 550-563 (Pubitemid 40138976)
8. Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med. 2003;9:669-676 (Pubitemid 36749215)
9. Ueda T, Takeyama Y, Yasuda T, et al. Vascular endothelial growth factor increases in serum and protects against the organ injuries in severe acute pancreatitis. J Surg Res. 2006;134: 223-230 (Pubitemid 44092803)
10. Ueda T, Takeyama Y, Toyokawa A, et al. Significant elevation of serum human hepatocyte growth factor levels in patients with acute pancreatitis. Pancreas. 1996;12:76-83 (Pubitemid 26004505)
11. Ueda T, Takeyama Y, Hori Y, et al. Hepatocyte growth factor in assessment of acute pancreatitis: comparison with C-reactive protein and interleukin-6. J Gastroenrerol. 1997;32:63-70 (Pubitemid 27075883)
12. Ueda T, Takeyama Y, Hori Y, et al. Hepatocyte growth factor increases in injured organs and functions as an organotrophic factor in rats with experimental acute pancreatitis. Pancreas. 2000;20:84-93 (Pubitemid 30022648)
13. Hosokawa M, Tsukada H, Fukuda F, et al. Therapeutic effect of basic growth factor on experimental pancreatitis in rat. Pancreas. 2000;20:373-377 (Pubitemid 30253649)
14. Liu LR, Xia SH. Role of platelet-activating factor in pathogenesis of acute pancreatitis. World J Gastroenterol. 2006;12:539-545
15. Ranson JH. Etiological and prognosis factors in human acute pancreatitis: a review. Am J Gastroenterol. 1982;77:633-638 (Pubitemid 12061420)
16. Blamey SL, Imrie CW, ONeill J, et al. Prognostic factors in acute pancreatitis. Gut. 1984;25:1340-1346 (Pubitemid 15180519)
17. Bradley EL III. A clinically based classification system for acute pancreatitis: summary of the international symposium on acute pancreatitis, Atlanta, Ga, September 11 through 13,1992. Arch Surg. 1993;128:586-590
18. Venkatesan T, Moulton JS, Ulrich CD II, et al. Prevalence and predictors of severity as defined by Atlanta criteria patients presenting with acute pancreatitis. Pancreas. 2003;26:107-110 (Pubitemid 36278293)
19. Ross R, Raines EW, Bowen-Pope DF. The biology of plateletderived growth factor. Cell. 1986;46:155-169
20. Siegbahn A, Hammacher A, Westermark B, et al. Differential effects of the various isoforms of platelet-derived growth factor on chemotaxis of fibroblasts, monocytes, and granulocytes. J Clin Invest. 1990;85:916-920 (Pubitemid 20087496)
21. Kumagai S, Ohtani H, Nagai T, et al. Platelet-derived growth factor and its receptors are expressed in areas of both active inflammation and active fibrosis in inflammatory bowel disease. Tohoku J Exp Med. 2001;195:21-33 (Pubitemid 34036883)
22. Ikura Y, Morimoto H, Ogami M, et al. Expression of plateletderived growth factor and its receptor in livers of patients with chronic liver disease. J Gastroenterol. 1997;32:496-501 (Pubitemid 27367980)
23. Pinzani M, Milani S, Herbst H, et al. Expression of plateletderived growth factor and its receptors in normal human liver and during active hepatic fibrogenesis. Am J Pathol. 1996; 148:785-800 (Pubitemid 126660671)
24. Warzecha Z, Dembiń ski A, Ceranowicz P, et al. Immunohistochemical expression of FGF-2, PDGF-A, VEGF and TGF beta RII in the pancreas in the course of ischemia/reperfusion-induced acute pancreatitis. J Physiol Pharmacol. 2004;55:791-810 (Pubitemid 40053046)
25. Dembiń ski A, Warzecha Z, Ceranowicz P, et al. Effect of ischemic preconditioning on pancreatic regeneration and pancreatic expression of vascular endothelial growth factor and platelet-derived growth factor-A in ischemia/reperfusioninduced pancreatitis. J Physiol Pharmacol. 2006;57:39-58
26. Mc Carty MF, Somcio RJ, Stoeltzing O, et al. Overexpression of PDGF-BB decreases colorectal and pancreatic cancer growth by increasing tumor pericyte content. J Clin Invest. 2007;117:2114-2122 (Pubitemid 47219556)
27. Maisonpierre PC, Suri C, Jones PF, et al. Angiopoietin-2, a natural antagonist for Tie-2 that disrupts in vivo angiogenesis. Science. 1997;277:48-50
28. Fiedler U, Krissl T, Koidl S, et al. Angiopoietin-1 and angiopoietin-2 share the same binding domains in the Tie-2 receptor involving the first Ig-like loop and the epidermal growth factor-like repeats. J Biol Chem. 2003; 278:1721-1727 (Pubitemid 36801406)
29. Fiedler U, Augustin HG. Angiopoietins: a link between angiogenesis and inflammation. Trends Immunol. 2006;27:552-558 (Pubitemid 44780853)
30. Tadros A, Hughes DP, Dunmore BJ, et al. ABIN-2 protects endothelial cells from death and has a role in the antiapoptotic effect of angiopoietin-1. Blood. 2003;102:4407-4409 (Pubitemid 37494102)
31. Scharpfenecker M, Fiedler U, Reiss Y, et al. The Tie-2 ligand Angiopoietin-2 destabilizes quiescent endothelium through an internal autocrine loop mechanism. J Cell Sci. 2005;118 (Pt 4):771-780 (Pubitemid 40372585)
32. Pfaff D, Fiedler U, Augustin HG. Emerging roles of the angiopoietin-Tie and the ephrin-Eph systems as regulators of cell trafficking. J Leukoc Biol. 2006;80:719-726 (Pubitemid 44835887)
33. Tashiro K, Hagiya M, Nishizawa T, et al. Deduced primary structure of rat hepatocyte growth factor and expression of the mRNA in rat tissues. Proc Nuti Acad Sci U S A. 1990;87: 3200-3204
34. Seki T, Ihara I, Sugimura A, et al. Isolation and expression of cDNA for different forms of hepatocyte growth factor from human leukocyte. Biochem Biophys Res Commun. 1990; 172:321-327 (Pubitemid 20352539)
35. Calvo EL, Boucher C, Pelletier G, et al. Ontogeny of hepatocyte growth factor and c-methgf receptor in rat pancreas. Biochem Biophys Res Commun. 1996;229:257-263 (Pubitemid 27013740)
36. Tsubouchi H, Niitani Y, Hirono S, et al. Levels of the human hepatocyte growth factor in serum of patients with various liver diseases determined by an enzyme-linked immunosorbent assay. Hepatology. 1991;13:1-5
37. Yanagita K, Matsumoto K, Sekiguchi K, et al. Hepatocyte growth factor may act as a pulmotrophic factor on lung regeneration after acute lung injury. J Biol Chem. 1993; 268:21212-21217 (Pubitemid 23292309)
38. Medina J, Caveda L, Sanz-Cameno P, et al. Hepatocyte growth factor activates endothelial proangiogenic mechanisms relevant in chronic hepatitis C-associated neoangiogenesis. J Hepatol. 2003;38:660-667 (Pubitemid 36560652)
39. Ishiki Y, Ohnishi H, Muto Y, et al. Direct evidence that hepatocyte growth factor is a hepatotrophic factor for liver regeneration and has a potent antihepatitis effect in vivo. Hepatology. 1992;16:1227-1235
40. Salcedo Mora X, Sanz-Cameno P, Medina J, et al. Association between angiogenesis soluble factors and disease progression markers in chronic hepatitis C patients. Rev Esp Enferm Dig. 2005;97:699-706 (Pubitemid 44323957)
41. Salcedo X, Medina J, Sanz-Cameno P, et al. The potential of angiogenesis soluble markers in chronic hepatitis C. Hepatology. 2005;42:696-701 (Pubitemid 41233664)